Sir: Tardive dyskinesia (TD) is a serious, potentially irreversible side effect of antipsychotic medications. Prevalence rates of 20% with the typical antipsychotics have been reported. 1 Although the risk is smaller, treatment with atypical antipsychotic agents still poses a risk of TD. There is 1 report of ziprasidone-related TD in a patient who had other risk factors for TD, including advanced age, female gender, and affective illness.
Aripiprazole is an atypical antipsychotic drug with a unique mechanism of action; it inhibits central dopaminergic neuron activity by a partial agonistic effect on the presynaptic D 2 dopamine autoreceptor and also acts as an antagonist at postsynaptic D 2 dopamine receptors. Through this mechanism, aripiprazole exerts activity as a dopamine agonist in hypodopaminergic states, while acting as a dopamine antagonist when dopaminergic activity is increased. 4 Alteration of the sensitivity of dopaminergic receptors to dopamine in the corpus striatum has been studied in experimental models, and it has been proposed that the lingualfacial-buccal dyskinesia seen in humans could be the human equivalent of stereotyped behavior seen in experimental animals with chronic chlorpromazine pretreatment. 5 There is also evidence from basic science studies that aripiprazole causes little D 2 receptor up-regulation. 6 Therefore, it is plausible that aripiprazole, by virtue of its dopamine agonistic activity, can potentially normalize D 2 dopamine receptor up-regulation. These properties may play a role in both prevention of the emergence of TD and the treatment of TD.
There is 1 other report of improvement of TD with aripiprazole in which improvement continued even after a conventional antipsychotic was added to the patient's regimen. 7 We propose that for schizophrenic patients who have tardive dyskinesia and who do not desire clozapine treatment or cannot be prescribed clozapine due to medical contraindications, aripiprazole may provide alternate pharmacotherapy to treat psychoses and tardive dyskinesia. However, more research is needed in this direction.
